4 Analysts Assess Roivant Sciences: What You Need To Know
Portfolio Pulse from Benzinga Insights
Roivant Sciences (NASDAQ:ROIV) has received mixed analyst ratings over the past three months, with a recent trend towards bullish sentiment. Analysts have set a 12-month price target range of $12.50 to $22.00, with an average target of $17.62, reflecting a 3.65% increase from the previous average. The company has shown strong revenue growth and profitability, but its return on equity lags behind industry averages.
September 11, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roivant Sciences has received a mix of bullish and neutral ratings from analysts, with a recent increase in average price target to $17.62. The company shows strong revenue growth and profitability, but its return on equity is below industry averages.
The recent analyst ratings show a trend towards bullish sentiment, with an increase in the average price target. This suggests positive market expectations. The company's strong revenue growth and profitability are positive indicators, although the lower ROE may be a concern for some investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100